Asbestosis: Clinical spectrum and pathogenic mechanisms

Proceedings of the Society for Experimental Biology and Medicine

Volumn 214, Issue 1, 1997, Pages 12-26

  Kamp, David W ^a   Weitzman, Sigmund A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS FIBER; COLLAGEN TYPE 3; CYTOKINE; FIBRONECTIN; GAMMA INTERFERON; HYDROXYL RADICAL; INTERLEUKIN 1; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ASBESTOSIS; DIAGNOSTIC TEST; DNA DAMAGE; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG TOXICITY; NONHUMAN; OCCUPATIONAL LUNG DISEASE; PATHOGENESIS; SHORT SURVEY; THORAX RADIOGRAPHY;

EID: 0031023784     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-214-44065     Document Type: Short Survey

References (149)

1. Mossman BT, Gee JBL. Medical progress: Asbestos-related diseases. N Engl J Med 320:1721-1730, 1989.
2. Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL. Asbestos: Scientific developments and implications for public policy. Science 247:294-301, 1990.
3. Cooke WE. Pulmonary asbestosis. Br Med J 2:1024-1025, 1927.
4. Murphy RL, Becklake MR, Brooks SM, et al. The diagnosis of non-malignant diseases related to asbestos. Am Rev Respir Dis 134:363-368, 1986.
5. Cordier S, Lazar P, Brochard P, Bignon J, Ameille J, Proteau J. Epidemiologic investigation of respiratory effects related to environmental exposure to asbestos inside insulated buildings. Arch Environ Health 42:303-309, 1987.
6. Oliver LC, Sprince NL, Greene R. Asbestos-related disease in public school custodians. Am J Indust Med 19:303-316, 1991.
7. Mannino D, Etzel R, Cobb N. Deaths with asbestosis in the United States, 1968 through 1988. Am Rev Respir Dis 145:334(A), 1992.
8. Henneberger PK, Stanbury MJ. Patterns of asbestosis in New Jersey. Am J Indust Med 21:689-697, 1992.
9. Rom WN, Travis WD, Brody AR. Cellular and molecular basis of asbestos-related diseases. Am Rev Respir Dis 143:408-422, 1991.
10. Kamp DW, Graceffa P, Prior WA, Weitzman SA. The role of free radicals in asbestos induced diseases. Free Radical Biol Med 12:293-315, 1992.
11. Everitt JI. Mechanisms of fiber-induced diseases: Implications for the safety evaluation of synthetic vitreous fibers. Regul Toxicol Pharmacol 20:568-570, 1994.
12. Barbers RG, Abraham JL. Asbestos occurring after a brief inhalational exposure: Usefulness of bronchoalveolar lavage in diagnosis. Br J Indust Med 46:106-110, 1989.
13. Chesson J, Hatfield J, Schultz B, Dutrow E, Blake J. Airborne asbestos in public buildings. Environ Res 51:100-107, 1990.
14. Sawyer RN, Spooner CM. Sprayed asbestos-containing material in buildings: A guidance document. U.S. Environmental Protection Agency EPA, 450:2, 1978.
15. Pleuropulmonary disease caused by inhalation of inorganic dust (pneumoconiosis). In: Fraser RG, Pare JAP, Pare PD, Fraser RS, Genereux GP, Eds. Diagnosis of Diseases of the Chest. Philadelphia: W. B. Saunders, Vol III: p2346, 1990.
16. Freundlich IM, Greening RR. Asbestos and associated medical problems. Radiology 89:224-229, 1967.
17. Kipen HM, Lilis R, Suzuki Y, Valciukas JA, Selikoff IJ. Pulmonary fibrosis in asbestos insulation workers with lung cancer: A radiological and histopathological evaluation. Br J Ind Med 44:96-100, 1987.
18. Aberle DR, Gamsu G, Ray CS, Feuerstein IM. Asbestos-related pleural and parenchymal fibrosis: Detection with high-resolution CT. Radiology 166:729-734, 1988.
19. Staples CA, Gamsu G, Ray CS, Webb WR. High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs. Am Rev Respir Dis 139:1502-1508, 1989.
20. Klaas VE. A diagnostic approach to asbestosis utilizing clinical criteria, high resolution computed tomography and gallium scanning. Am J Indust Med 23:801-809, 1993.
21. Lynch D, Webb WR, Gamsu G, et al. CT and HRCT of asbestos-related lung and pleural disease. Radiographics 9:523, 1989.
22. Delclos GL, Flitcraft DG, Brousseau KP, Windsor NT, Nelson DL, Wilson RK, Lawrence EC. Bronchoalveolar lavage analysis, gallium-67 lung scanning and soluble interleukin-2 receptor levels in asbestos exposure. Environ Res 48:164-178, 1989.
23. Miller A. Pulmonary function in asbestosis and asbestos-related pleural disease. Environ Res 61:1-18, 1993.
24. Roggli VL. Human disease consequences of fiber exposures: A review of human lung pathology and fiber burden data. Environ Health Perspect 88:295-303, 1990.
25. Miller A, Lilis R, Godbold J, Chan E, Selikoff I. Relationship of pulmonary function to radiographic interstitial fibrosis in 2,611 long-term asbestos insulators. Am Rev Respir Dis 145:263-270, 1992.
26. Jones RN. The diagnosis of asbestosis. Am Rev Respir Dis 144:477-478, 1991.
27. Craighead JE, Abraham JL, Churg A, Green FHY, Kleinerman J, Pratt PC, Seemayer TA, Vallyathan V, Weill H. The pathology of asbestos-associated diseases of the lungs and pleural cavities: Diagnostic criteria and proposed grading schema. Arch Pathol Lab Med 106:540-597, 1982.
28. Henderson DW, Roggli VL, Shilkin KB, Hammar SP, Leigh J. Is asbestosis an obligate precursor for asbestos-related lung cancer? In: Peters GA, Peters BJ, Eds. Asbestos Health Effects, Treatment and Control. Charlottesville: The Michie Company, Vol 11:pp103-169, 1995.
29. Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 144:689-696, 1991.
30. De Vuyst P, Jedwab J, Dumortier P, Vandermoten G, Vande Weyer R, Yemault JC. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis 126:972-976, 1982.
31. Sebastien, Armstrong B, Monchaux G, Bignon J. Asbestos bodies in bronchoalveolar lavage fluid and in the lung parenchyma. Am Rev Respir Dis 137:75-78, 1988.
32. Schwatz DA, Galvin JR, Burmeister LF, Merchant RK, Dayton CS, Merchant JA, Hunninghake GW. The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid. Am Rev Respir Dis 144:684-688, 1991.
33. Becklake MR. Asbestos and other fiber-related diseases of the lungs and pleura. Chest 100:248-254, 1991.
34. Berry G. Mortality of workers certified by pneumoconiosis medical panel as having asbestosis. Br J Indust Med 38:130-137, 1981.
35. Doll R. Mortality from lung cancer in asbestos workers. Br J Indust Med 12:81-86, 1955.
36. Davis JMG, Cowie HA. The relationship between fibrosis and cancer in experimental animals exposed to asbestos and other fibers. Environ Health Perspect 88:305-309, 1990.
37. Hughes JM, Weill H. Asbestosis as a precursor of asbestos-related lung cancer: Results of a prospective mortality study. Br J Indust Med 48:229-233, 1991.
38. Abraham JL. Asbestos inhalation, not asbestosis, causes lung cancer. Am J Indust Med 26:839-842, 1994.
39. Wilkinson P, Hansell DM, Janssens J, Rubens M, Rudd RM, Taylor AN, McDonald C. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet 345:1074-1078, 1995.
40. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35:496-499, 1980.
41. Bellis D, Andrion A, Delsedime L, Mollo F. Minimal pathologic changes of the lung and asbestos exposure. Hum Pathol 20:102-106, 1989.
42. Brody AR, Hill LH, Adkins B, O'Connor RW. Chrysotile asbestos inhalation in rats: Deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 123:670-679, 1981.
43. Pinkerton KE, Pratt PC, Brody AR, Crapo JD. Fiber localization and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos. Am J Pathol 117:484-493, 1984.
44. Churg A, Green FHY. Occupational lung disease. In: Thurlbeck WM, Churg AM, Eds. Pathology of the Lung (2nd ed). New York: Thieme, pp851-929, 1995.
45. Arden MG, Adamson IYR. Collagen synthesis and degradation during the development of asbestos-induced pulmonary fibrosis. Exp Lung Res 18:9-20, 1992.
46. Becklake MR. Fiber burden and asbestos-related lung disease: Determinants of dose-response relationships. Am J Respir Crit Care Med 150:1488-1492, 1994.
47. Hardy JA, Aust AE. Iron in asbestos chemistry and carcinogenicity. Chem Rev 95:97-118, 1995.
48. Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and by peritoneal injection. J Exp Pathol 67:415-430, 1986.
49. Churg A, Wright JL, Vedal S. Fiber burden and patterns of asbestos related disease in chrysotile miners and millers. Am Rev Respir Dis 148:25-31, 1993.
50. Churg A, Vedal S. Fiber burden and patterns of asbestos related disease in workers with heavy mixed exposure to amosite and chrysotile. Am J Respir Crit Care Med 150:663-669, 1994.
51. Hart GA, Kathman LM, Hesterberg TW. In vitro cytotoxicity of asbestos and man-made vitreous fibers: Role of fiber length, diameter, and composition. Carcinogenesis 15:971-977, 1994.
52. Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: A review of the amphibole hypothesis. Am J Public Health 86:179-186, 1996.
53. Cullen MR. Annotation: The amphibole hypothesis of asbestos-related cancer - Gone but not forgotten. Am J Public Health 86:158-159, 1996.
54. Shull S, Manohar M, Marsh JP, Janssen YMN, Mossman BT. Role of iron and reactive oxygen species in asbestos-induced lung injury. In: Moslen MT, Smith CV, Eds. Free Radical Mechanisms of Tissue Injury. Boca Raton, FL: CRC Press, pp153-162, 1992.
55. Timbrell V. Characteristics of the international union against cancer standard reference samples of asbestos. In: Shapiro HA, Ed. Pneumoconiosis: Proceedings of the International Conference. Oxford: Oxford University Press, pp28-36, 1970.
56. Weitzman SA, Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 228:373-376, 1984.
57. Lund LG, Aust AE. Iron mobilization from asbestos by chelators and ascorbic acid. Arch Biochem Biophys 278:60-64, 1990.
58. Chao CC, Aust AE. Effect of long-term removal of iron from asbestos by desferrioxamine B on subsequent mobilization by other chelators and induction of DNA single strand breaks. Arch Biochem Biophys 308:64-69, 1994.
59. Lund LG, Williams MG, Dodson RF, Aust AE. Iron associated with asbestos bodies is responsible for the formation of single strand breaks in phi X174 RFI DNA. Occup Environ Med 51:200-204, 1995.
60. Hardy JA, Aust AE. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16:319-325, 1995.
61. Ghio AJ, Kennedy TP, Whorton R, Crumbliss AL, Hatch GE, Hoidal JR. Role of surface complexed iron in oxidant generation and lung inflammation induced by silicates. Am J Physiol 263(Lung Cell Mol Physiol 7):L511-L518, 1992.
62. Vaino H, Buffetta P. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health 20:235-242, 1994.
63. Jackson JH, Schraufstatter IU, Hyslop PA, Vosbeck K, Sauerheber RD, Weitzman SA, Cochrane CG. Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. J Clin Invest 80:1090-1095, 1987.
64. Vallyathan V, Mega JF, Shi X, Dalal NS. Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Respir Cell Mol Biol 6:404-413, 1992.
65. Garcia JGN, Griffith DE, Cohen AB, Callahan KS. Alveolar macrophage from patients with asbestos exposure release increased levels of leukotriene B4. Am Rev Respir Dis 139:1494-1501, 1989.
66. Schwartz DA, Galvin JR, Merchant RK, Dayton CS, Burmeister LF, Merchant JA, Hunninghake GW. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease. Am Rev Respir Dis 145:400-405, 1992.
67. Robinson BWS, Rose AH, Haye A, Musk AW. Increased pulmonary gamma interferon production in asbestosis. Am Rev Respir Dis 138:278-283, 1988.
68. Goodglick LA, Kane AB. Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res 50:5153-5163, 1990.
69. Roney PL, Holian A. Possible mechanisms of chrysotile asbestos-stimulated superoxide anion production in guinea pig alveolar macrophages. Toxicol Appl Pharmacol 100:132-144, 1989.
70. Sesko A, Cabot M, Mossman B. Hydrolysis of inositol phospholipids precedes cellular proliferation in asbestos-stimulated tracheobronchial epithelial cells. Proc Natl Acad Sci U S A 87:7385-7389, 1990.
71. Pryor WA. On the detection of lipid hydroperoxides in biological samples. Free Rad Biol Med 5:177-178, 1989.
72. Weiss SJ. Tissue destruction by activated neutrophils. N Engl J Med 329:265-276, 1989.
73. Goodglick LA, Kane AB. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res 46:5558-5566, 1986.
74. Mossman BT, Marsh JP, Shatos MA. Alteration of superoxide dismutase activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants. Lab Invest 54:204-212, 1986.
75. Garcia JGN, Gray LD, Dodson RF, Callahan KD. Asbestos-induced endothelial cell activation and injury. Am Rev Respir Dis 138:958-964, 1988.
76. Kamp DW, Dunne M, Anderson JA, Weitzman SA, Dunn MM. Serum promotes asbestos-induced lung injury to human pulmonary epithelial cells. J Lab Clin Med 116:289-297, 1990.
77. Shatos MA, Doherty JM, Marsh JP, Mossman BT. Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species. Environ Res 44:103-116, 1987.
78. Kamp DW, Dunne M, Weitzman SA, Dunn MM. The interaction of asbestos and neutrophils injures cultured human pulmonary epithelial cells: Role of hydrogen peroxide. J Lab Clin Med 114:604-612, 1989.
79. Kamp DW, Sbalchiero JM, Knap AM, Dunn MM, Weitzman SA. Contrasting effects of alveolar macrophages and neutrophils on asbestos-induced pulmonary epithelial cell injury. Am J Physiol 266(Lung Cell Mol Physiol 10):L84-L91, 1994.
80. McDonald RJ, Berger EM, Repine JE. Alveolar macrophage antioxidants prevent hydrogen peroxide-mediated lung damage. Am Rev Respir Dis 43:1088-1091, 1991.
81. Tron V, Wright JL, Harrison N, Wiggs B, Chung A. Cigarette smoke makes airway and early parenchymal asbestos-induced lung disease worse in the guinea pig. Am Rev Respir Dis 136:271-275, 1987.
82. Hobson J, Wright JL, Churg A. Active oxygen species mediate asbestos fiber uptake by tracheal epithelial cells. FASEB J 4:3135-3139, 1990.
83. Churg A, Hobson J, Berean K, Wright J. Scavengers of active oxygen species prevent cigarette smoke-induced asbestos fiber penetration in rat tracheal explants. Am J Pathol 135:599-603, 1989.
84. Shull S, Heitz NH, Periasamy M, Manohan M, Janssen YMW, Marsh JP, Mossman BT. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 266:24398-24403, 1991.
85. Janssen YM, Barchowsky A, Treadwell M, Driscoll KE, Mossman BT. Asbestos induces nuclear factor NF-κB DNA-binding activity and NF-κB-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A 92:8458-8462, 1995.
86. LaRosa FA, Pierce JW, Sonenshein GE. Differential regulation of the c-myc oncogene promoter by the NF-kappa-B rel family of transcription factors. Mol Cell Biol 14:1039-1044, 1994.
87. Thomas G, Ando T, Verma K, Kagan E. Asbestos fibers and interferon-7 up-regulate nitric oxide production in rat alveolar macrophages. Am J Respir Cell Mol Biol 11:707-715, 1994.
88. Chao CC, Park SH, Aust AE. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophy 326:152-157, 1996.
89. Gutierrez HH, Pitt BR, Schwartz M, Watkins SC, Lowenstein C, Caniggia I, Chumley P, Freeman BA. Pulmonary alveolar epithelial inducible nitric oxide synthetase gene expression: Regulation by inflammatory mediators. Am J Physiol 268(Lung Cell Mol Physiol 12):L501-L508, 1995.
90. Adcock IM, Brown CR, Kwon O, Barnes PJ. Oxidative stress induces NF-κB DNA-binding and inducible nitric oxide synthetase mRNA in human epithelial cells. Biochem Biophys Res Commun 199:1518-1524, 1995.
91. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 268(Lung Cell Mol Physiol 12):L699-L722, 1995.
92. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med 37:93-101, 1995.
93. Donaldson K, Cullen RT. Chemiluminescence of asbestos activated macrophages. Br J Exp Pathol 65:81-90, 1984.
94. Cantin A, DuBois F, Begin R. Lung exposure to mineral dusts enhances the capacity of lung inflammatory cells to release superoxide. J Leuko Biol 43:299-303, 1988.
95. Petruska JM, Marsh J, Bergeron M, Mossman BT. Brief inhalation of asbestos compromises superoxide production in cells from bronchoalveolar lavage. Am J Respir Cell Mol Biol 2:129-136, 1990.
96. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, Kogan E. Inhibition of lung injury, inflammation and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 141:1266-1271, 1990.
97. Janssen YMW, Marsh JP, Absher MP, Hemenway D, Vacek PM, Leslie KP, Borm PJA, Mossman BT. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J Biol Chem 267:10625-10630, 1992.
98. Quinlan TR, BeruBe KA, Marsh JP, Janssen YMW, Taishi P, Leslie KO, Hemenway D, O'Shaughnessy PT, Vacek P, Mossman BT. Patterns of inflammation, cell proliferation and related gene expression in lung cells after inhalation of chrysotile asbestos. Am J Pathol 147:728-739, 1995.
99. Schapira RM, Ghio AJ, Effros RM, Morrisey J, Dawson CA, Hacker AD. Hydroxyl radicals are formed in the rat lung after asbestos instillation in vivo. Am J Respir Cell Mol Biol 10:573-579, 1994.
100. Kamp DW, Israbian VA, Yeldandi A, Panos RJ, Graceffa P, Weitzman SA. Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicol Pathol 23:689-695, 1995.
101. Freeman BA, Mason RJ, Williams MC, Crapo JD. Antioxidant enzyme activity in alveolar Type II cells after exposure of rats to hyperoxia. Exp Lung Res 10:203-222, 1986.
102. Holley JA, Janssen YMW, Mossman BY, Taatjes DJ. Increased manganese superoxide dismutase protein in type II epithelial cells of rat lungs after inhalation of crocidolite asbestos or cristobalite silica. Am J Pathol 141:475-485, 1992.
103. White CW, Abraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 87:2162-2168, 1991.
104. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsberg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack of overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232-237, 1996.
105. Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin K, Christiani DC. Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. Curr Epidemiol Biomarkers Prev 3:471-477, 1994.
106. Kamal A-AM, Gomaa A, Khafif ME, Hammad AS. Plasmid lipid peroxides among workers exposed to silica or asbestos dusts. Environ Res 49:173-180, 1989.
107. Goodglick LA, Pietra LA, Kane AB. Evaluation of the causal relationship between crocidolite asbestos-induced lipid peroxidation and toxicity to macrophages. Am Rev Respir Dis 139:1265-1273, 1989.
108. Cochrane CG, Schraufstatler IU, Hyslop P, Jackson J. Cellular and biochemical events of oxidant injury. In: Halliwell B, Ed. Oxygen Radicals and Tissue Injury. Bethesda, MD: Upjohn Company, pp49-53, 1988.
109. Pryor WA. Why is hydroxyl radical the only radical the commonly adds to DNA? Hypothesis: It has a rare combination of high electrophilicity, high thermochemical reactivity, and a mode of production that can occur near DNA. Free Rad Biol Med 4:219-223, 1988.
110. Aruoma OI, Halliwell B, Dizdaroglu M. Iron ion-dependent modification of bases in DNA by superoxide induced-generating system hypoxanthine/xanthine oxidase. J Biol Chem 264:13024-13028, 1989.
111. Bradley MO, Erikson LC. Comparison of the effects of hydrogen peroxide and x-ray irradiation on toxicity, mutation and DNA damage/repair in mammalian cells (V-79). Biochem Biophys Acta 654:125-141, 1981.
112. Kasai H, Nishimura S. DNA damage induced by asbestos in the presence of hydrogen peroxide. Gann Monogr Cancer Res 75:841-844, 1984.
113. Leanderson P, Soderkvist P, Tagesson C, Axelson O. Formation of 8-hydroxydeoxy-guanosine by asbestos and man made mineral fibers. Br J Ind Med 45:309-311, 1988.
114. Leanderson P, Soderkvist P, Tagesson C. Hydroxyl radical mediated DNA base modification by manmade mineral fibers. Br J Ind Med 46:435-438, 1989.
115. Fornace AJ, Lechner JR, Graftstrom RC, Harris CC. DNA repair in human bronchial epithelial cells. Carcinogenesis 3:1373-1377, 1982.
116. Kodama Y, Boreiko CJ, Manese SC, Hesterberg TW. Cytotoxic and cytogenetic effects of asbestos on human bronchial epithelial cells in culture. Carcinogenesis 14:691-697, 1993.
117. Mossman BT, Eastman A, Landsman JM, Bresnick E. Effects of crocidolite and chrysotile asbestos on cellular uptake and metabolism of benzo(a)pyrene in hamster tracheal epithelial cells. Environ Health Perspect 51:331-325, 1983.
118. Turver CJ, Brown RC. The role of catalytic iron in asbestos-induced lipid peroxidation and DNA-strand breakage in C3H10T 1/2 cells. Br J Cancer 56:133-136, 1987.
119. Libbus BL, Illenye SA, Craighead JE. Induction of DNA strand breaks in cultured rat embryo cells by crocidolite asbestos as assessed by nick translation. Cancer Res 49:5713-5718, 1989.
120. Kamp DW, Israbian VA, Preusen SE, Zhang CX, Weitzman SA. Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: Role of iron catalyzed free radicals. Am J Physiol 268(Lung Cell Mol Physiol 12):L471-L480, 1995.
121. Takeuchi T, Morimoto K. Crocidolite asbestos increased 8-hydroxydeoxyguanosine levels in cellular DNA of a human promyelocytic leukemia cell line, HL60. Carcinogenesis 15:635-639, 1994.
122. McBride TJ, Preston BD, Loeb LA. Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry 30:207-213, 1991.
123. 32P-postlabeling of DNA adducts induced by a Fenton-type oxygen radical generating system. Carcinogenesis 13:1127-1135, 1992.
124. Hei TK, Prao CQ, He ZY, Vannais D, Waldren CA. Chrysotile fiber is a strong mutagen in mammalian cells. Cancer Res 52:6305-6309, 1992.
125. Leanderson P, Tagesson C. Hydrogen peroxide release and hydroxyl radical formation in mixtures containing mineral fibers and human neutrophils. Br J Indust Med 49:745-749, 1992.
126. Weitzman SA, Gordon LI. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 76:655-663, 1990.
127. Marsh JP, Mossman BT. Role of asbestos and active oxygen species in activation and expression of omithine decarboxylase in hamster tracheal epithelial cells. Cancer Res 51:167-173, 1991.
128. Perderiset M, Marsh JP, Mossman BT. Activation of protein kinase C by crocidolite asbestos in hamster tracheal epithelial cells. Carcinogenesis 12:1499-1502, 1991.
129. Woodworth CD, Mossman BT, Craighead JE. Induction of squamous metaplasia in organ culture of hamster trachea by naturally occurring and synthetic fibers. Cancer Res 43:4905-4912, 1983.
130. Radosevich CA, Weitzman SA. Hydrogen peroxide induces squamous metaplasia in a hamster tracheal organ explant culture model. Carcinogenesis 10:1943-1946, 1989.
131. Crawford D, Zbinden I, Amstad P, Cerutti P. Oxidant stress induces the protooncogenes c-fos and c-myc in mouse epidermal cells. Oncogene 3:27-32, 1988.
132. Muehlematter D, Larsson R, Cerutti P. Active oxygen induced DNA strand breakage and poly ADP ribosylation in promotable and nonpromotable JB6 mouse epidermal cells. Carcinogenesis 9:239-245, 1988.
133. Amstad P, Cerutti P. Genetic modulation of cellular antioxidant defense capacity. Environ Health Perspect 88:77-82, 1990.
134. Begin R, Ostiguy G, Filion R, Groleau S. Recent advances in the early diagnosis of asbestosis. Semin Roentgenol 27:121-139, 1992.
135. Perkett EA. Role of growth factors in lung repair and diseases. Curr Opin Pediatr 7:242-249, 1995.
136. Bonner JC, Brody AR. Cytokine-binding proteins in the lung. Am J Physiol 268(Lung Cell Mol Physiol 12):L869-L878, 1995.
137. Rom WN. Relationship of inflammatory cell cytokines to disease severity in individuals with occupational inorganic dust exposure. Am J Indust Med 19:15-27, 1991.
138. Bonner JC, Goodell AL, Coin PG, Brody AR. Chrysotile asbestos up-regulates gene expression and production of alpha receptors for PDGF-AA on rat lung fibroblasts. J Clin Invest 92:425-430, 1993.
139. Lasky JA, Coin PG, Lindroos PM, Ostrowski LE, Brody AR, Bonner JC. Chrysotile asbestos stimulates PDGF-AA production by rat lung fibroblasts in vitro: Evidence for an autocrine loop. Am J Respir Cell Mol Biol 12:162-170, 1995.
140. Morris GF, Liu JY, Lei W-H, Brody AR. Expression of genes coding for growth factors in experimental pneumoconiosis. Chest 109:545-549, 1996.
141. Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN. Enhanced IL-1β and tumor necrosis factor-alpha release and mRNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150:188-196, 1993.
142. Piquet PF, Ribaux C, Karuz V, Grau GE, Kapanci Y. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 143:651-655, 1993.
143. Goldstein RH, Fine A. Potential therapeutic initiatives for fibrogenic lung disease. Chest 108:848-855, 1995.
144. Kayanoki Y, Fujii J, Suzuki K, Kawata S, Matsuawa Y, Taniguchi N. Suppression of antioxidant enzyme expression by transforming growth factor-β1 in rat hepatocytes. J Biol Chem 269:15488-15492, 1994.
145. Khali N, O'Connor RN, Unnh HW, Warren PW, Flanders KC, Kemp A, Bereznny OH, Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5:155-162, 1991.
146. Perdue TD, Brody AR. Distribution of transforming growth factor-β1, fibronectin and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J Histochem Cytochem 42:1061-1070, 1994.
147. Bornstein P, Sage H. Regulation of collagen gene expression. Prog Nucleic Acid Res Mol Biol 37:67-105, 1989.
148. Kang KY, Sera Y, Okochi T, Yamamura Y. T lymphocytes in asbestosis. N Engl J Med 291:735-736, 1974.
149. Corsini E, Luster MI, Mahler J, Craig WA, Blazka ME, Rosenthal GJ. A potential role for lymphocytes in asbestos-induced pulmonary inflammation and collagen deposition. Am J Respir Cell Mol Biol 11:531-539, 1994.